Effect of short-term estrogen therapy on endothelial function: a double-blinded, randomized, controlled trial

References

• Schächinger V, Zeiher AM. Prognostic implications of endothelial dysfunction: does it mean anything? Coron Artery Dis 2001;12:435–44
   PubMed Web of Science ®Google Scholar
• Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL. Weight gain at the time of menopause. Arch Intern Med 1991;151:97–102
   PubMed Web of Science ®Google Scholar
• Cho GJ, Lee JH, Park HT, et al. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause 2008;15:524–9
   PubMed Web of Science ®Google Scholar
• Kolovou GD, Bilianou HG. Influence of aging and menopause on lipids and lipoproteins in women. Angiology 2008;59:54–7S
   PubMed Web of Science ®Google Scholar
• Farhat MY, Levigne MC, Ramwell PW. The vascular protective effects of estrogens. FASEB J 1996;10:615–24
   PubMed Web of Science ®Google Scholar
• Oger E, Alhenc-Gelas M, Plu-Bureau G, et al. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users. Thromb Res 2001;101:35–43
   PubMed Web of Science ®Google Scholar
• Sendag F, Karadadas N, Ozsener S, Bilgin O. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women. Arch Gynecol Obstet 2002;266:38–43
   PubMedGoogle Scholar
• Mikkola T, Viinikka L, Ylikorkala O. Estrogen and postmenopausal estrogen/progestin therapy: effect on endothelium dependent prostacyclin, nitric oxide and endothelin-1 production. Eur J Obstet Gynecol Reprod Biol 1998;79:75–82
   PubMed Web of Science ®Google Scholar
• Ylikorkala O, Cacciatore B, Paakkani I, Tikkanen MJ, Viinikka L, Toivonen J. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin and thromboxane. Fertil Steril 1998;69:883–8
   PubMed Web of Science ®Google Scholar
• Chester AH, Jiang C, Borlano JA, Yacoub M, Colllins P. Oestrogen relaxes human epicardial arteries through non-endothelial dependent mechanisms. Coron Artery Dis 1995;6:417–22
   PubMed Web of Science ®Google Scholar
• Colburn P, Buonassisi V. Estrogen-binding sites in endothelial cell cultures. Science 1978;201:817–19
   PubMed Web of Science ®Google Scholar
• Battaglia C, Regnani G, Artini PG, et al. Uterine and cerebral vascularization in postmenopausal women treated with hormone-replacement therapy. Gynecol Endocrinol 1999;13:223–9
   PubMed Web of Science ®Google Scholar
• Van Baal WM, Kenemans P, Stehouwe CD, Peters-Muller ER, Van Vugt JM, Van Der Mooren MJ. Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women. Am J Obstet Gynecol 1999;181:1365–73
   PubMed Web of Science ®Google Scholar
• Faria AF, de Souza MA, Geber S. Vascular resistance of central retinal artery is reduced in postmenopausal women after use of estrogen. Menopause 2011;18:869–72
   PubMed Web of Science ®Google Scholar
• Corretti MC, Anderson TJ, Benjamin EJ, et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257–65
   PubMed Web of Science ®Google Scholar
• Thijssen DH, Black MA, Pyke KE, et al. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 2011;300:H2–12
   PubMed Web of Science ®Google Scholar
• McCrohon JA, Adams MR, McCredie RJ, et al. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. Clin Endocrinol 1996;45:435–41
   PubMed Web of Science ®Google Scholar
• Akman L, Duygu H, Akercan F, Ulukus M, Ozerkan F, Akin M. The effects of different hormone treatment on endothelial function in healthy postmenopausal women. Gynecol Endocrinol 2013;29:867–72
   PubMed Web of Science ®Google Scholar
• Vitale C, Mercuro G, Cerquetani E, et al. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 2008;28:348–52
   PubMed Web of Science ®Google Scholar
• Bechlioulis A, Kalantaridou SN, Naka KK, et al. Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severe hot flushes. J Clin Endocrinol Metab 2010;95:1199–206
   PubMed Web of Science ®Google Scholar
• Bechlioulis A, Naka KK, Kalantaridou SN, et al. Short-term hormone therapy improves sCD40L and endothelial function in early menopausal women: Potential role of estrogen receptor polymorphisms. Maturitas 2012;71:389–95
   PubMed Web of Science ®Google Scholar
• Dubey RK, Imthurn B, Barton M, Jackson EK. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc Res 2005;66:295–306
   PubMed Web of Science ®Google Scholar
• Sutton-Tyrrell K, Lassila HC, Meilahn E, Bunker C, Matthews KA, Kuller LH. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 1998;29:1116–21
   PubMed Web of Science ®Google Scholar
• Christian RC, Liu PY, Harrington S, Ruan M, Miller VM, Fitzpatrick LA. Intimal estrogen receptor (ER) beta, but not ER alpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women. J Clin Endocrinol Metab 2006;91:2713–20
   PubMed Web of Science ®Google Scholar
• Serock MR, Wells AK, Khalil RA. Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency states associated with menopause. Recent Pat Cardiovasc Drug Discov 2008;3:165–86
   PubMedGoogle Scholar
• Luotola H. Blood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitution. Ann Clin Res 1983;15(Suppl 38):1–121
   PubMedGoogle Scholar
• Smiley DA, Khalil RA. Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels. Curr Med Chem 2009;16:1863–87
   PubMed Web of Science ®Google Scholar
• Campisi R, Nathan L, Pampaloni MH, et al. Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration. Circulation 2002;105:425–30
   PubMed Web of Science ®Google Scholar